SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Xylem Inc. – ‘10-Q’ for 6/30/22 – ‘EX-101.SCH’

On:  Tuesday, 8/2/22, at 11:54am ET   ·   For:  6/30/22   ·   Accession #:  1524472-22-34   ·   File #:  1-35229

Previous ‘10-Q’:  ‘10-Q’ on 5/4/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/1/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 10/31/23 for 9/30/23   ·   3 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/02/22  Xylem Inc.                        10-Q        6/30/22   94:11M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.57M 
 2: EX-10.1     Material Contract                                   HTML     48K 
 3: EX-10.2     Material Contract                                   HTML     57K 
 4: EX-10.3     Material Contract                                   HTML    134K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
14: R1          Cover Page                                          HTML     82K 
15: R2          Condensed Consolidated Income Statements            HTML    108K 
                (Unaudited)                                                      
16: R3          Condensed Consolidated Statements of Comprehensive  HTML     73K 
                (Loss) Income (Unaudited)                                        
17: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML    143K 
18: R5          Condensed Consolidated Balance Sheets (Unaudited)   HTML     36K 
                (Parenthetical)                                                  
19: R6          Condensed Consolidated Statements of Cash Flows     HTML    113K 
                (Unaudited)                                                      
20: R7          Background and Basis of Presentation                HTML     32K 
21: R8          Revenue                                             HTML    119K 
22: R9          Restructuring Charges                               HTML    113K 
23: R10         Income Taxes                                        HTML     32K 
24: R11         Earnings Per Share                                  HTML     63K 
25: R12         Inventories                                         HTML     33K 
26: R13         Goodwill and Other Intangible Assets                HTML     66K 
27: R14         Derivative Financial Instruments                    HTML     79K 
28: R15         Accrued and Other Current Liabilities               HTML     36K 
29: R16         Credit Facilities and Debt                          HTML     54K 
30: R17         Post-retirement Benefit Plans                       HTML     63K 
31: R18         Equity                                              HTML    135K 
32: R19         Share-Based Compensation Plans                      HTML     87K 
33: R20         Capital Stock                                       HTML     28K 
34: R21         Accumulated Other Comprehensive Income (Loss)       HTML    116K 
35: R22         Commitments and Contingencies                       HTML     41K 
36: R23         Segment Information                                 HTML     96K 
37: R24         Background and Basis of Presentation (Policies)     HTML     30K 
38: R25         Revenue (Tables)                                    HTML    116K 
39: R26         Restructuring Charges (Tables)                      HTML    115K 
40: R27         Earnings Per Share (Tables)                         HTML     63K 
41: R28         Inventories (Tables)                                HTML     34K 
42: R29         Goodwill and Other Intangible Assets (Tables)       HTML     67K 
43: R30         Derivative Financial Instruments (Tables)           HTML     71K 
44: R31         Accrued and Other Current Liabilities (Tables)      HTML     36K 
45: R32         Credit Facilities and Debt (Tables)                 HTML     44K 
46: R33         Post-retirement Benefit Plans (Tables)              HTML     58K 
47: R34         Equity (Tables)                                     HTML    131K 
48: R35         Share-Based Compensation Plans (Tables)             HTML     94K 
49: R36         Accumulated Other Comprehensive Income (Loss)       HTML    116K 
                (Tables)                                                         
50: R37         Commitments and Contingencies (Tables)              HTML     34K 
51: R38         Segment Information (Tables)                        HTML     91K 
52: R39         Background and Basis of Presentation (Details)      HTML     27K 
53: R40         Revenue - Disaggregation of Revenue (Details)       HTML     84K 
54: R41         Revenue (Details)                                   HTML     43K 
55: R42         Revenue (Narrative) (Details)                       HTML     32K 
56: R43         Restructuring Charges (Textuals) (Details)          HTML     46K 
57: R44         Restructuring Charges (Restructuring Charges)       HTML     46K 
                (Details)                                                        
58: R45         Restructuring Charges (Accrual Rollfoward)          HTML     50K 
                (Details)                                                        
59: R46         Restructuring Charges (Estimated Restructuring      HTML     63K 
                Costs) (Details)                                                 
60: R47         Income Taxes (Textuals) (Details)                   HTML     33K 
61: R48         Earnings Per Share (Calculations for EPS)           HTML     74K 
                (Details)                                                        
62: R49         Earnings Per Share (Summary of Antidilutive         HTML     35K 
                Securities) (Details)                                            
63: R50         Inventories (Details)                               HTML     34K 
64: R51         Goodwill and Other Intangible Assets (Goodwill      HTML     38K 
                Rollforward) (Details)                                           
65: R52         Goodwill and Other Intangible Assets (Summary of    HTML     60K 
                Intangible Assets) (Details)                                     
66: R53         Goodwill and Other Intangible Assets (Details       HTML     28K 
                Textual)                                                         
67: R54         Derivative Financial Instruments (Effect of         HTML     60K 
                Deriative Instruments on Income Statement and                    
                Statement of Comprehensive Income) (Details)                     
68: R55         Derivative Financial Instruments (Balance Sheet     HTML     41K 
                Location of Derivative Instruments) (Details)                    
69: R56         Derivative Financial Instruments (Details Textual)  HTML     71K 
70: R57         Accrued and Other Current Liabilities (Details)     HTML     41K 
71: R58         Credit Facilities and Debt (Summary of Debt         HTML     59K 
                Outstanding) (Details)                                           
72: R59         Credit Facilities and Debt (Textuals) (Details)     HTML     93K 
73: R60         Post-retirement Benefit Plans (Summary of Net       HTML     47K 
                Periodic Benefit Cost) (Details)                                 
74: R61         Post-retirement Benefit Plans (Textuals) (Details)  HTML     43K 
75: R62         Equity - Summary of Shareholders' Equity (Details)  HTML     90K 
76: R63         Share-Based Compensation Plans (Textuals)           HTML     51K 
                (Details)                                                        
77: R64         Share-Based Compensation Plans (Summary of Stock    HTML     75K 
                Options Grant) (Details)                                         
78: R65         Share-Based Compensation Plans (Stock Option Fair   HTML     38K 
                Value Assumptions) (Details)                                     
79: R66         Share-Based Compensation Plans (Summary of          HTML     54K 
                Restricted Stock Unit Grants) (Details)                          
80: R67         Share-Based Compensation Plans Share-Based          HTML     45K 
                Compensation Plans (Summary of ROIC Performance                  
                Share Unit Grants) (Details)                                     
81: R68         Share-Based Compensation Plans (Summary of          HTML     54K 
                Performance-Based Share Grants) (Details)                        
82: R69         Share-Based Compensation Plans (TSR                 HTML     37K 
                Performance-Based Shares Fair Value Assumptions)                 
                (Details)                                                        
83: R70         Share-Based Compensation Plans - Summary of REV     HTML     44K 
                Performance Share Unit Grants (Details)                          
84: R71         Capital Stock (Textuals) (Details)                  HTML     44K 
85: R72         Accumulated Other Comprehensive Income (Loss)       HTML     84K 
                (Details)                                                        
86: R73         Commitments and Contingencies (Summary of           HTML     33K 
                Warranties) (Details)                                            
87: R74         Commitments and Contingencies (Details Textual)     HTML     31K 
88: R75         Segment Information (Summary of Operations by       HTML     74K 
                Segment) (Details)                                               
89: R76         Segment Information (Textuals) (Details)            HTML     26K 
92: XML         IDEA XML File -- Filing Summary                      XML    171K 
90: XML         XBRL Instance -- xyl-20220630_htm                    XML   3.42M 
91: EXCEL       IDEA Workbook of Financial Reports                  XLSX    158K 
10: EX-101.CAL  XBRL Calculations -- xyl-20220630_cal                XML    168K 
11: EX-101.DEF  XBRL Definitions -- xyl-20220630_def                 XML    718K 
12: EX-101.LAB  XBRL Labels -- xyl-20220630_lab                      XML   1.59M 
13: EX-101.PRE  XBRL Presentations -- xyl-20220630_pre               XML   1.08M 
 9: EX-101.SCH  XBRL Schema -- xyl-20220630                          XSD    165K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              419±   641K 
94: ZIP         XBRL Zipped Folder -- 0001524472-22-000034-xbrl      Zip    497K

‘EX-101.SCH’   —   XBRL Schema — xyl-20220630

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- Copyright 2022 Workiva -->
<!-- r:9699a27b-36b6-49b1-a7c6-a5b45693f859,g:250859d5-a7ab-4875-9bb9-635f9debcc5d -->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xyl="http://www.xyleminc.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.xyleminc.com/20220630">
<xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
<xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
<xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<xs:annotation>
<xs:appinfo>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xyl-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xyl-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xyl-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xyl-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:roleType id="CoverPage" roleURI="http://www.xyleminc.com/role/CoverPage">
<link:definition> 0001001 - Document - Cover Page </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedIncomeStatementsUnaudited" roleURI="http://www.xyleminc.com/role/CondensedConsolidatedIncomeStatementsUnaudited">
<link:definition> 1001002 - Statement - Condensed Consolidated Income Statements (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedStatementsofComprehensiveLossIncomeUnaudited" roleURI="http://www.xyleminc.com/role/CondensedConsolidatedStatementsofComprehensiveLossIncomeUnaudited">
<link:definition> 1002003 - Statement - Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.xyleminc.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
<link:definition> 1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.xyleminc.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
<link:definition> 1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.xyleminc.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
<link:definition> 1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BackgroundandBasisofPresentation" roleURI="http://www.xyleminc.com/role/BackgroundandBasisofPresentation">
<link:definition> 2101101 - Disclosure - Background and Basis of Presentation </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BackgroundandBasisofPresentationPolicies" roleURI="http://www.xyleminc.com/role/BackgroundandBasisofPresentationPolicies">
<link:definition> 2202201 - Disclosure - Background and Basis of Presentation (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BackgroundandBasisofPresentationDetails" roleURI="http://www.xyleminc.com/role/BackgroundandBasisofPresentationDetails">
<link:definition> 2403401 - Disclosure - Background and Basis of Presentation (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Revenue" roleURI="http://www.xyleminc.com/role/Revenue">
<link:definition> 2104102 - Disclosure - Revenue </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueTables" roleURI="http://www.xyleminc.com/role/RevenueTables">
<link:definition> 2305301 - Disclosure - Revenue (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueDisaggregationofRevenueDetails" roleURI="http://www.xyleminc.com/role/RevenueDisaggregationofRevenueDetails">
<link:definition> 2406402 - Disclosure - Revenue - Disaggregation of Revenue (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueDetails" roleURI="http://www.xyleminc.com/role/RevenueDetails">
<link:definition> 2407403 - Disclosure - Revenue (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueNarrativeDetails" roleURI="http://www.xyleminc.com/role/RevenueNarrativeDetails">
<link:definition> 2408404 - Disclosure - Revenue (Narrative) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueNarrativeDetails_1" roleURI="http://www.xyleminc.com/role/RevenueNarrativeDetails_1">
<link:definition> 2408404 - Disclosure - Revenue (Narrative) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RestructuringCharges" roleURI="http://www.xyleminc.com/role/RestructuringCharges">
<link:definition> 2109103 - Disclosure - Restructuring Charges </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RestructuringChargesTables" roleURI="http://www.xyleminc.com/role/RestructuringChargesTables">
<link:definition> 2310302 - Disclosure - Restructuring Charges (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RestructuringChargesTextualsDetails" roleURI="http://www.xyleminc.com/role/RestructuringChargesTextualsDetails">
<link:definition> 2411405 - Disclosure - Restructuring Charges (Textuals) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RestructuringChargesRestructuringChargesDetails" roleURI="http://www.xyleminc.com/role/RestructuringChargesRestructuringChargesDetails">
<link:definition> 2412406 - Disclosure - Restructuring Charges (Restructuring Charges) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RestructuringChargesAccrualRollfowardDetails" roleURI="http://www.xyleminc.com/role/RestructuringChargesAccrualRollfowardDetails">
<link:definition> 2413407 - Disclosure - Restructuring Charges (Accrual Rollfoward) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RestructuringChargesEstimatedRestructuringCostsDetails" roleURI="http://www.xyleminc.com/role/RestructuringChargesEstimatedRestructuringCostsDetails">
<link:definition> 2414408 - Disclosure - Restructuring Charges (Estimated Restructuring Costs) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxes" roleURI="http://www.xyleminc.com/role/IncomeTaxes">
<link:definition> 2115104 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesTextualsDetails" roleURI="http://www.xyleminc.com/role/IncomeTaxesTextualsDetails">
<link:definition> 2416409 - Disclosure - Income Taxes (Textuals) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EarningsPerShare" roleURI="http://www.xyleminc.com/role/EarningsPerShare">
<link:definition> 2117105 - Disclosure - Earnings Per Share </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EarningsPerShareTables" roleURI="http://www.xyleminc.com/role/EarningsPerShareTables">
<link:definition> 2318303 - Disclosure - Earnings Per Share (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EarningsPerShareCalculationsforEPSDetails" roleURI="http://www.xyleminc.com/role/EarningsPerShareCalculationsforEPSDetails">
<link:definition> 2419410 - Disclosure - Earnings Per Share (Calculations for EPS) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EarningsPerShareSummaryofAntidilutiveSecuritiesDetails" roleURI="http://www.xyleminc.com/role/EarningsPerShareSummaryofAntidilutiveSecuritiesDetails">
<link:definition> 2420411 - Disclosure - Earnings Per Share (Summary of Antidilutive Securities) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Inventories" roleURI="http://www.xyleminc.com/role/Inventories">
<link:definition> 2121106 - Disclosure - Inventories </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InventoriesTables" roleURI="http://www.xyleminc.com/role/InventoriesTables">
<link:definition> 2322304 - Disclosure - Inventories (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InventoriesDetails" roleURI="http://www.xyleminc.com/role/InventoriesDetails">
<link:definition> 2423412 - Disclosure - Inventories (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.xyleminc.com/role/GoodwillandOtherIntangibleAssets">
<link:definition> 2124107 - Disclosure - Goodwill and Other Intangible Assets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.xyleminc.com/role/GoodwillandOtherIntangibleAssetsTables">
<link:definition> 2325305 - Disclosure - Goodwill and Other Intangible Assets (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillRollforwardDetails" roleURI="http://www.xyleminc.com/role/GoodwillandOtherIntangibleAssetsGoodwillRollforwardDetails">
<link:definition> 2426413 - Disclosure - Goodwill and Other Intangible Assets (Goodwill Rollforward) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandOtherIntangibleAssetsSummaryofIntangibleAssetsDetails" roleURI="http://www.xyleminc.com/role/GoodwillandOtherIntangibleAssetsSummaryofIntangibleAssetsDetails">
<link:definition> 2427414 - Disclosure - Goodwill and Other Intangible Assets (Summary of Intangible Assets) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandOtherIntangibleAssetsDetailsTextual" roleURI="http://www.xyleminc.com/role/GoodwillandOtherIntangibleAssetsDetailsTextual">
<link:definition> 2428415 - Disclosure - Goodwill and Other Intangible Assets (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.xyleminc.com/role/DerivativeFinancialInstruments">
<link:definition> 2129108 - Disclosure - Derivative Financial Instruments </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.xyleminc.com/role/DerivativeFinancialInstrumentsTables">
<link:definition> 2330306 - Disclosure - Derivative Financial Instruments (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeFinancialInstrumentsEffectofDeriativeInstrumentsonIncomeStatementandStatementofComprehensiveIncomeDetails" roleURI="http://www.xyleminc.com/role/DerivativeFinancialInstrumentsEffectofDeriativeInstrumentsonIncomeStatementandStatementofComprehensiveIncomeDetails">
<link:definition> 2431416 - Disclosure - Derivative Financial Instruments (Effect of Deriative Instruments on Income Statement and Statement of Comprehensive Income) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeFinancialInstrumentsBalanceSheetLocationofDerivativeInstrumentsDetails" roleURI="http://www.xyleminc.com/role/DerivativeFinancialInstrumentsBalanceSheetLocationofDerivativeInstrumentsDetails">
<link:definition> 2432417 - Disclosure - Derivative Financial Instruments (Balance Sheet Location of Derivative Instruments) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeFinancialInstrumentsDetailsTextual" roleURI="http://www.xyleminc.com/role/DerivativeFinancialInstrumentsDetailsTextual">
<link:definition> 2433418 - Disclosure - Derivative Financial Instruments (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AccruedandOtherCurrentLiabilities" roleURI="http://www.xyleminc.com/role/AccruedandOtherCurrentLiabilities">
<link:definition> 2134109 - Disclosure - Accrued and Other Current Liabilities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AccruedandOtherCurrentLiabilitiesTables" roleURI="http://www.xyleminc.com/role/AccruedandOtherCurrentLiabilitiesTables">
<link:definition> 2335307 - Disclosure - Accrued and Other Current Liabilities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AccruedandOtherCurrentLiabilitiesDetails" roleURI="http://www.xyleminc.com/role/AccruedandOtherCurrentLiabilitiesDetails">
<link:definition> 2436419 - Disclosure - Accrued and Other Current Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CreditFacilitiesandDebt" roleURI="http://www.xyleminc.com/role/CreditFacilitiesandDebt">
<link:definition> 2137110 - Disclosure - Credit Facilities and Debt </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CreditFacilitiesandDebtTables" roleURI="http://www.xyleminc.com/role/CreditFacilitiesandDebtTables">
<link:definition> 2338308 - Disclosure - Credit Facilities and Debt (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CreditFacilitiesandDebtSummaryofDebtOutstandingDetails" roleURI="http://www.xyleminc.com/role/CreditFacilitiesandDebtSummaryofDebtOutstandingDetails">
<link:definition> 2439420 - Disclosure - Credit Facilities and Debt (Summary of Debt Outstanding) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CreditFacilitiesandDebtTextualsDetails" roleURI="http://www.xyleminc.com/role/CreditFacilitiesandDebtTextualsDetails">
<link:definition> 2440421 - Disclosure - Credit Facilities and Debt (Textuals) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PostretirementBenefitPlans" roleURI="http://www.xyleminc.com/role/PostretirementBenefitPlans">
<link:definition> 2141111 - Disclosure - Post-retirement Benefit Plans </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PostretirementBenefitPlansTables" roleURI="http://www.xyleminc.com/role/PostretirementBenefitPlansTables">
<link:definition> 2342309 - Disclosure - Post-retirement Benefit Plans (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PostretirementBenefitPlansSummaryofNetPeriodicBenefitCostDetails" roleURI="http://www.xyleminc.com/role/PostretirementBenefitPlansSummaryofNetPeriodicBenefitCostDetails">
<link:definition> 2443422 - Disclosure - Post-retirement Benefit Plans (Summary of Net Periodic Benefit Cost) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PostretirementBenefitPlansTextualsDetails" roleURI="http://www.xyleminc.com/role/PostretirementBenefitPlansTextualsDetails">
<link:definition> 2444423 - Disclosure - Post-retirement Benefit Plans (Textuals) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Equity" roleURI="http://www.xyleminc.com/role/Equity">
<link:definition> 2145112 - Disclosure - Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityTables" roleURI="http://www.xyleminc.com/role/EquityTables">
<link:definition> 2346310 - Disclosure - Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquitySummaryofShareholdersEquityDetails" roleURI="http://www.xyleminc.com/role/EquitySummaryofShareholdersEquityDetails">
<link:definition> 2447424 - Disclosure - Equity - Summary of Shareholders' Equity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlans" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlans">
<link:definition> 2148113 - Disclosure - Share-Based Compensation Plans </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlansTables" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlansTables">
<link:definition> 2349311 - Disclosure - Share-Based Compensation Plans (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlansTextualsDetails" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlansTextualsDetails">
<link:definition> 2450425 - Disclosure - Share-Based Compensation Plans (Textuals) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlansSummaryofStockOptionsGrantDetails" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlansSummaryofStockOptionsGrantDetails">
<link:definition> 2451426 - Disclosure - Share-Based Compensation Plans (Summary of Stock Options Grant) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlansStockOptionFairValueAssumptionsDetails" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlansStockOptionFairValueAssumptionsDetails">
<link:definition> 2452427 - Disclosure - Share-Based Compensation Plans (Stock Option Fair Value Assumptions) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlansSummaryofRestrictedStockUnitGrantsDetails" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlansSummaryofRestrictedStockUnitGrantsDetails">
<link:definition> 2453428 - Disclosure - Share-Based Compensation Plans (Summary of Restricted Stock Unit Grants) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlansShareBasedCompensationPlansSummaryofROICPerformanceShareUnitGrantsDetails" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlansShareBasedCompensationPlansSummaryofROICPerformanceShareUnitGrantsDetails">
<link:definition> 2454429 - Disclosure - Share-Based Compensation Plans Share-Based Compensation Plans (Summary of ROIC Performance Share Unit Grants) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlansSummaryofPerformanceBasedShareGrantsDetails" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlansSummaryofPerformanceBasedShareGrantsDetails">
<link:definition> 2455430 - Disclosure - Share-Based Compensation Plans (Summary of Performance-Based Share Grants) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlansTSRPerformanceBasedSharesFairValueAssumptionsDetails" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlansTSRPerformanceBasedSharesFairValueAssumptionsDetails">
<link:definition> 2456431 - Disclosure - Share-Based Compensation Plans (TSR Performance-Based Shares Fair Value Assumptions) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationPlansSummaryofREVPerformanceShareUnitGrantsDetails" roleURI="http://www.xyleminc.com/role/ShareBasedCompensationPlansSummaryofREVPerformanceShareUnitGrantsDetails">
<link:definition> 2457432 - Disclosure - Share-Based Compensation Plans - Summary of REV Performance Share Unit Grants (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CapitalStock" roleURI="http://www.xyleminc.com/role/CapitalStock">
<link:definition> 2158114 - Disclosure - Capital Stock </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CapitalStockTextualsDetails" roleURI="http://www.xyleminc.com/role/CapitalStockTextualsDetails">
<link:definition> 2459433 - Disclosure - Capital Stock (Textuals) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.xyleminc.com/role/AccumulatedOtherComprehensiveIncomeLoss">
<link:definition> 2160115 - Disclosure - Accumulated Other Comprehensive Income (Loss) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.xyleminc.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
<link:definition> 2361312 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.xyleminc.com/role/AccumulatedOtherComprehensiveIncomeLossDetails">
<link:definition> 2462434 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingencies" roleURI="http://www.xyleminc.com/role/CommitmentsandContingencies">
<link:definition> 2163116 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.xyleminc.com/role/CommitmentsandContingenciesTables">
<link:definition> 2364313 - Disclosure - Commitments and Contingencies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingenciesSummaryofWarrantiesDetails" roleURI="http://www.xyleminc.com/role/CommitmentsandContingenciesSummaryofWarrantiesDetails">
<link:definition> 2465435 - Disclosure - Commitments and Contingencies (Summary of Warranties) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingenciesDetailsTextual" roleURI="http://www.xyleminc.com/role/CommitmentsandContingenciesDetailsTextual">
<link:definition> 2466436 - Disclosure - Commitments and Contingencies (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformation" roleURI="http://www.xyleminc.com/role/SegmentInformation">
<link:definition> 2167117 - Disclosure - Segment Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformationTables" roleURI="http://www.xyleminc.com/role/SegmentInformationTables">
<link:definition> 2368314 - Disclosure - Segment Information (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformationSummaryofOperationsbySegmentDetails" roleURI="http://www.xyleminc.com/role/SegmentInformationSummaryofOperationsbySegmentDetails">
<link:definition> 2469437 - Disclosure - Segment Information (Summary of Operations by Segment) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformationTextualsDetails" roleURI="http://www.xyleminc.com/role/SegmentInformationTextualsDetails">
<link:definition> 2470438 - Disclosure - Segment Information (Textuals) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xs:appinfo>
</xs:annotation>
<xs:element id="xyl_RestructuringReserveAssetImpairmentCosts" abstract="false" name="RestructuringReserveAssetImpairmentCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_SegmentInformationTextualAbstract" abstract="true" name="SegmentInformationTextualAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="xyl_StandardProductWarrantyAccrualOther" abstract="false" name="StandardProductWarrantyAccrualOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
<xs:element id="xyl_SellCDNBuyEURMember" abstract="true" name="SellCDNBuyEURMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_BuyKRSellEURMember" abstract="true" name="BuyKRSellEURMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_SeniorNotesDueTwoThousandFortySixMember" abstract="true" name="SeniorNotesDueTwoThousandFortySixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_CommercialBuildingServicesMember" abstract="true" name="CommercialBuildingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_REVPerformanceSharesMember" abstract="true" name="REVPerformanceSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_LineofCreditFacilityIncreasesinMaximumBorrowingCapacity" abstract="false" name="LineofCreditFacilityIncreasesinMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_SellASDBuyEuroMember" abstract="true" name="SellASDBuyEuroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_BuyUSDSellCDNMember" abstract="true" name="BuyUSDSellCDNMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
<xs:element id="xyl_FiveYearRevolvingCreditFacility2019Member" abstract="true" name="FiveYearRevolvingCreditFacility2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ResidentialBuildingServicesMember" abstract="true" name="ResidentialBuildingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_CashPaidDuringYearForAbstract" abstract="true" name="CashPaidDuringYearForAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="xyl_USDollarCommercialPaperProgramMember" abstract="true" name="USDollarCommercialPaperProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ScheduleOfComponentsOfRestructuringAndAssetImpairmentChargesTableTextBlock" abstract="false" name="ScheduleOfComponentsOfRestructuringAndAssetImpairmentChargesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
<xs:element id="xyl_ProprietaryandPatentedTechnologyMember" abstract="true" name="ProprietaryandPatentedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_BuyPLNSellEURMember" abstract="true" name="BuyPLNSellEURMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_RestructuringReserveAssetImpairment" abstract="false" name="RestructuringReserveAssetImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_ScheduleofSharebasedPaymentAwardEquityInstrumentsOtherthanOptionsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleofSharebasedPaymentAwardEquityInstrumentsOtherthanOptionsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
<xs:element id="xyl_ContractWithCustomerLiabilityAdditions" abstract="false" name="ContractWithCustomerLiabilityAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_SeniorNotesDueTwentyTwentyEightMember" abstract="true" name="SeniorNotesDueTwentyTwentyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_AccumulatedOtherComprehensiveIncomeLossRollForward" abstract="true" name="AccumulatedOtherComprehensiveIncomeLossRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="xyl_LineofCreditFacilityIncreasesinMaximumBorrowingCapacityTotal" abstract="false" name="LineofCreditFacilityIncreasesinMaximumBorrowingCapacityTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_RegionalSellingLocationMemberMember" abstract="true" name="RegionalSellingLocationMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_SettlementofEmployeeTaxWithholdingObligationsMember" abstract="true" name="SettlementofEmployeeTaxWithholdingObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_TwoThousandTwentyRestructuringPlanMember" abstract="true" name="TwoThousandTwentyRestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ScheduleOfEarningsPerShareBasicAndDilutedLineItems" abstract="true" name="ScheduleOfEarningsPerShareBasicAndDilutedLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="xyl_ReturnonInvestedCapitalPerformanceBasedSharesMember" abstract="true" name="ReturnonInvestedCapitalPerformanceBasedSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_SeniorNotesDueTwoThousandAndTwentyThreeMember" abstract="true" name="SeniorNotesDueTwoThousandAndTwentyThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_SellGBPBuyEURMember" abstract="true" name="SellGBPBuyEURMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_AssetImpairmentandRestructuringCharges" abstract="false" name="AssetImpairmentandRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_StockBasedCompensationPlansTextualAbstract" abstract="true" name="StockBasedCompensationPlansTextualAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="xyl_TreatmentMember" abstract="true" name="TreatmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_TotalShareholderReturnPerformanceBasedSharesMember" abstract="true" name="TotalShareholderReturnPerformanceBasedSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_OtherRevenues" abstract="false" name="OtherRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_ElectricMember" abstract="true" name="ElectricMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="xyl_SeniorNotesDueTwoThousandTwentySixMember" abstract="true" name="SeniorNotesDueTwoThousandTwentySixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_MeasurementandControlSolutionsMember" abstract="true" name="MeasurementandControlSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_EmergingMarketsMember" abstract="true" name="EmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ContractWithCustomerAssetNewContractAdditions" abstract="false" name="ContractWithCustomerAssetNewContractAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_ScheduleOfEarningsPerShareBasicAndDilutedTable" abstract="true" name="ScheduleOfEarningsPerShareBasicAndDilutedTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
<xs:element id="xyl_EuroCommercialPaperProgramMember" abstract="true" name="EuroCommercialPaperProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_IndustrialWaterMember" abstract="true" name="IndustrialWaterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_GreenBondMember" abstract="true" name="GreenBondMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ScheduleOfRestructuringAccrualsTableTextBlock" abstract="false" name="ScheduleOfRestructuringAccrualsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
<xs:element id="xyl_AppliedWaterMember" abstract="true" name="AppliedWaterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ShareRepurchasePlansMember" abstract="true" name="ShareRepurchasePlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ContractWithCustomerLiabilityOther" abstract="false" name="ContractWithCustomerLiabilityOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_RestructuringAndAssetImpairmentLosses" abstract="false" name="RestructuringAndAssetImpairmentLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_ScheduleOfIntangibleAssetsExcludingGoodwillTableTextBlock" abstract="false" name="ScheduleOfIntangibleAssetsExcludingGoodwillTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
<xs:element id="xyl_SeniorNotesDueTwentyThirtyOneMember" abstract="true" name="SeniorNotesDueTwentyThirtyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_RedemptionPricePercentage" abstract="false" name="RedemptionPricePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="xyl_TransportMember" abstract="true" name="TransportMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_WaterInfrastructureMember" abstract="true" name="WaterInfrastructureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_TwoThousandNineteenRestructuringPlanMember" abstract="true" name="TwoThousandNineteenRestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_CustomerRelatedLiabilitiesCurrent" abstract="false" name="CustomerRelatedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_ContractWithCustomerAssetOther" abstract="false" name="ContractWithCustomerAssetOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_TwoThousandfifteenStockRepurchaseProgramMember" abstract="true" name="TwoThousandfifteenStockRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" abstract="true" name="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="xyl_WesternEuropeMember" abstract="true" name="WesternEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_SellUSDBuyEURMember" abstract="true" name="SellUSDBuyEURMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="xyl_OtherGeographicalRegionsMember" abstract="true" name="OtherGeographicalRegionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="xyl_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentCostOfRevenueBeforeTax" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentCostOfRevenueBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="xyl_DerivativeInstrumentsGainsLossesInStatementOfFinancialPerformanceAbstract" abstract="true" name="DerivativeInstrumentsGainsLossesInStatementOfFinancialPerformanceAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Xylem Inc.                        10-K       12/31/23  152:19M
 2/24/23  Xylem Inc.                        10-K       12/31/22  143:18M

1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/15/17  Xylem Inc.                        8-K:5,9     5/10/17    3:275K
↑Top
Filing Submission 0001524472-22-000034   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 10:59:58.1pm ET